PULSLI: Advancing Healthcare with Proven Fluid Overload Prediction Technology

CHF:
$15B in preventable hospitalizations

What is needed to reduce
hospitalizations?

An AI-enabled fluid overload predictor built on

clinically validated

technology for remote patient self-monitoring, that is

widely deployed

due to its cost-effectiveness and non-invasiveness. Designed to maximize

patient compliance

, this highly engaging solution significantly reduces the

workload of health professionals

through its automated and integrated user experience.

Many hospitalizations

are treated with aggressive

IV diuresis, early detection of

fluid retention in outpatient

setting can lead to substantial

cost savings compared to

hospital admissions.

Greene et al., 2020

“It has been postulated that

approximately 2/3 of all CHF admissions

who require simply aggressive IV diuresis

may be effectively treated as outpatients,

resulting in billions of dollars in savings.”

ClinicoEconomics and

Outcomes Research

Zilberberg et al., 2023

ClinicoEconomics and Outcomes Research

Zilberberg et al., 2023

“It has been postulated that approximately 2/3 of all CHF admissions who require simply aggressive IV diuresis may be effectively treated as outpatients, resulting in billions of dollars in savings.”

Agency for Healthcare Research and Quality

Kimberly, McDermott, & Jiang (2020)

“The most common and most expensive reason for potentially preventable stays was heart failure for adults (1,112,600 stays and $11.2 billion in aggregate hospital costs)”

CHF: $15B in preventable hospitalizations

What is needed to reduce hospitalizations?

An AI-enabled fluid overload predictor built on clinically validated technology for remote patient self-monitoring, that is widely deployed due to is cost-effectiveness and non-invasiveness. Designed to maximize patient compliance, this highly engaging solution significantly reduces the workload of health professionals through its automated and integrated user experience.

Meet Pulsli

Pulsli's platform is centered around our patients. It features the first clinically validated predictor for fluid overload.

Our technology uses automation, integration, and AI to help reduce hospitalizations.

Pulsli utilizes a patented technology, and we have filed for multiple additional patents.

We are currently in the final stages of FDA approval through the 510(k) process.

The pioneering model of a predictor was in clinical evaluation at a Research Hospital in Vienna, Austria.

Read more about the underyling reasons and motivations behind our technology and actions

Discover The Rationale

Features

Simple and motivating

We understand how important the patient experience is and that is why we designed Pulsli with ease of use and engagement in focus.

Starting from onboarding, through each measurement that takes less then 30 seconds, Pulsli aims to empower patients and allow them to again own their condition.

Save on time and resources

To make sure we realize this promise, Pulsli is focusing on truly reducing the workload on medical professionals.

Our product leverages automation, integration with Electronic Health Records (EHRs) and delivers a clean and simple user experience, while leveraging AI to bring false positives to a minimum.

Together towards improved outcomes

How to create the best product? Engage with the users! Your feedback has been fueling our vision and innovation.